Scott Reents

Scott Reents

Director Financiero/CFO en TOBIRA THERAPEUTICS INC .

Fortuna: 10 M $ al 30/06/2026

59 años
Health Technology
Consumer Services

Perfil

Scott T.
Reents
currently serves as President & Director at Allergan, Inc., Celsius Therapeutics, Inc., Oculeve, Inc., and Allergan GI Corp.
He is Chief Financial Officer & Executive Vice President at AbbVie, Inc. since 2022, Chief Financial Officer at Tobira Therapeutics, Inc., Manager at Pharmacyclics LLC, and President at Landos Biopharma, Inc. Formerly, Mr. Reents was President & Director at Cerevel Therapeutics Holdings, Inc. and Vice President-Tax at Abbott Laboratories.
Education includes undergraduate studies at the University of Nebraska and graduate studies including an MBA at the University of Washington.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
06/03/2026 38.777 ( 0 % ) 10 M $ 30/06/2026

Cargos activos de Scott Reents

EmpresasCargoInicio
TOBIRA THERAPEUTICS INC Director Financiero/CFO -
ABBVIE INC. Director Financiero/CFO 23/06/2022
ALLERGAN, INC. Presidente -
LANDOS BIOPHARMA, INC. Presidente -
PHARMACYCLICS, INC. Corporate Officer/Principal -
Presidente -
Presidente -
Presidente -

Antiguos cargos conocidos de Scott Reents.

EmpresasCargoFin
CEREVEL THERAPEUTICS HOLDINGS, INC. Presidente -
░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ -
Ver el detalle de la experiencia de Scott Reents.

Formación de Scott Reents.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

37

Relaciones de 1er grado

12

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas12

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology